Skip to content

Blood Pressure Management on Cardiovascular Adverse Events After Major Abdominal Surgery (BP-CARES): a Randomized Controlled Trial

Blood Pressure Management on Cardiovascular Adverse Events After Major Abdominal Surgery (BP-CARES): a Randomized Controlled Trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000033672
Enrollment
Unknown
Registered
2020-06-08
Start date
2020-06-08
Completion date
Unknown
Last updated
2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular events after non-cardiac surgery

Interventions

Intensive intraoperative blood pressure management group:Target intraoperative MAP at or above 80 mmHg
Conventional intraoperative blood pressure management group:Target intraoperative MAP at or above 65 mmHg

Sponsors

Southern Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. The age is more than or equal to 45 years old; 2. It is planned to carry out large-scale abdominal operation under general anesthesia (the estimated operation time is more than 2 hours, and the postoperative hospitalization time is more than 2 days); 3. The patient has one or more of the following four diseases: (1) Coronary heart disease; (2) Stroke; (3) Peripheral arterial disease; (4) Congestive heart failure; (5) NT proBNP was more than 200 pg / ml or BNP was more than 92 mg / L before operation; (6) The preoperative troponin level was higher than the upper limit of normal range, or the patient had two or more of the following cardiovascular risk factors: (7) Chronic kidney disease (CR > 133 µ mol / L or 1.5 mg / dl before operation); (8) Diabetes requiring medication; (9) Smoking (continued for at least 2 years); (10) Aged 65 years and above; (11) Hypertension requiring medication; (12) Hypercholesterolemia.

Exclusion criteria

Exclusion criteria: 1. Patients with ASA grade >= 5; 2. Severe hypertension patients with poor preoperative control (systolic blood pressure > 180mmhg or diastolic blood pressure > 110mmhg); 3. Patients with end-stage renal disease requiring renal replacement therapy; 4. Patients with acute cardiovascular and cerebrovascular events (including heart failure, acute coronary syndrome and stroke in the past 1 month); 5. Patients diagnosed as sepsis before operation; 6. Patients who need to receive vasoactive drugs before operation; 7. Patients who are participating in another intervention clinical study; 8. Patients who have participated in this study; 9. Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
Major adverse cardiac events (a composite of myocardial injury/infarction, new-onset clinically important arrhythmia, heart failure, stroke, cardiac arrest, and all-cause death after surgery);

Secondary

MeasureTime frame
Major non-cardiovascular complications;Days alive and out of hospital;Disability-free survival;

Countries

China

Contacts

Public ContactKexuan Liu

Southern Hospital of Southern Medical University

liukexuan705@163.com+86 13710684096

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026